Alzheimer’s Disease

• 11/3/2024

  Biogen’s Q3 Earnings Beat Expectations, Driven by Alzheimer’s Breakthrough

• 10/23/2024

  “Revolutionizing Alzheimer’s Treatment: BioArctic’s Leqembi Breakthrough”

• 10/22/2024

  Annovis Bio’s Phase 3 Trials: Can They Secure Funding?

• 10/20/2024

  Buy Alert: Eli Lilly’s Undervalued Stock Poised for Massive Growth

• 10/18/2024

  Alzheimer’s Breakthrough: Annovis Bio Advances Clinical Trials

• 10/6/2024

  **2 Stocks Poised to Join the Trillion-Dollar Club by 2030**

• 9/30/2024

  **INmune Bio’s INKmune: A New Approach for mCRPC Treatment**

• 9/28/2024

  **FDA Approves Groundbreaking Schizophrenia Treatment**

• 9/28/2024

  **Unstoppable Growth Stock Soaring to $2 Trillion by 2030**